Dr. Khan Sujoy

Dr. Khan Sujoy

Consultant Allergist & Immunologist

Apollo Gleneagles Hospital Kolkata
Kolkatta, India

plus Speciality



Qualifications: 1. 2011: FRCP (Edin) Adult Internal Medicine, Royal College of Physicians of Edinburgh 2. 2010: FRCPath (Immunology), Royal College of Pathologists, London 3. 2008: DRCPath (Immunology), Royal College of Pathologists, London 4. 2004: MRCP (UK) Adult Internal Medicine, Royal College of Physicians of Edinburgh 5. 1999: MBBS, CMC Vellore, The Tamil Nadu Dr MGR Medical University, Chennai, India

Academic positions:

Employment History 1. 01 September 2010 – 15 June 2012: Consultant Immunologist; Frimley Park Hospital NHS Foundation Trust, Frimley, Camberley, Surrey, GU16 7UJ,United Kingdom 2. 01 September 2010 – 15 June 2012): Honorary Contract; Consultant Immunologist, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, GU2 7XX, United Kingdom 3. 1st Nov 2005 – 1st July 2010: Specialist Registrar Immunology; Scunthorpe General Hospital & Hull Royal Infirmary 4. 2008 - 2010: Honorary Clinical Fellow of Centre for Immunoglobulin Therapy 5. May 2005 – August 2005: Specialist Registrar Immunology, St Bartholomew’s Hospital & Mile End Hospital, London Achievements, prizes and grants 1. 2012: Biographee in ‘Who's Who in Science and Engineering’ 2011-2012 (11th Edition) 2. 2011: Biographee in ‘Who’s Who in the World 2012’ 28th Edition, Marquis Who’s Who, USA 3. 2011: Interview by ‘BBC South Today’ on ‘Allergies and Oral Allergy Syndrome’ – aired 24th August 4. 2010: Biographee in ‘Dictionary of International Biography’ 35th Edition, Cambridge, England 5. 2009: Biographee in ‘Who’s Who in the World’ 26th Edition, Marquis Who’s Who, USA 6. 2008: Biographee in ‘Dictionary of International Biography’ 34th Edition, Cambridge, England 7. 2007: Biographee in ‘Who’s Who in Science and Engineering’ 2008-2009 10th Edition, the Marquis Who’s Who publications board, USA 8. 2007: Recipient of Myre Sim Research grant, Royal College of Physicians of Edinburgh 9. 2000: 2nd in Annual General Medi Quiz, Apollo Hospital, Chennai, India 10. 1999: Undergraduate Research award, CMC Vellore, India 11. 1999: 3rd in annual undergraduate quiz in psychiatry (CMC Vellore, India) 12. 1998: Best paper Neurology “Stem-cell transplantation in neurodegenerative diseases” 13. 1997: Best paper Anatomy: Parotid Gland; Physiology: Erythropoietin 14. 1996: Best paper Biochemistry: RNA Editing (Annual essay competition CMC Vellore) 1st certificate of honor: Biochemistry, Forensic Medicine (CMC Vellore, India) 2nd certificate of honor: Anatomy, Physiology, Pharmacology, Pathology, Microbiology and Community Medicine (CMC Vellore, India)

Research interests:

Allergy, Immunology,

Any other information:

Publications 1. Khan S. Comparison of cytokine responses with anti-D and IVIG in ITP. Transfusion Medicine and Hemotherapy 2012 (in press). 2. Khan S. The pitfalls of FeNO testing. Allergology International 2012 (in press). 3. Khan S. Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes. Indian J Ophthal 2012 (in press). 4. Khan S. Chronic urticaria and use of statins. Asia Pacific J Allergy 2012 Jul; 2(3): 227-9. 5. Khan S. Coeliac disease and granulomatous gut complications in common variable immunodeficiency disorders. J R Coll Physicians Edinb. 2012 June; 42(2): 189-190. 6. Khan S, Lynch N. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria. Inflamm Allergy Drug Targets 2012 June 1; 11(3): 235-243. 7. Philip S, Khan S. The finding of anticardiolipin antibodies in patients with pseudoexfoliation syndrome requires further evaluation. Journal of Glaucoma 2012 March; 21(3): 206. 8. Khan S. Abnormal IL-7 signalling may lead to loss of bone mineral density in common variable immunodeficiency. Paed Allergy Immunol 2012 March; 23(2): 202. 9. Khan S. The role of hypoxia-inducible factor-1 alpha in TEMPI syndrome. Neph Dialysis Transplantation Plus 2011 December; 4(6): 454-5. 10. Khan S. PLA2R autoantibodies, complement activation and podocyte damage. Neph Dialysis Transplantation 2011 December; 26(12): 4151. 11. Khan S, Korniyenko A, Meserli FH. Angioedema secondary to renin inhibitor aliskiren. Cleve Clin J Med 2011 Nov; 78(11): 722. 12. Sujoy Khan. Serum N-glycan profiles in advanced age correlate with markers of fibrosis. Age Ageing 2011 [E-letter] available at: http://ageing.oxfordjournals.org/content/40/5/568/reply#ageing_el_249 [16 September 2011] 13. Khan S. Antiphospholipid syndrome as cause of cognitive decline or dementia in the elderly. J R Coll Physicians Edinb. 2011 Jun; 41(2): 187-9. 14. Khan S, Deacock S. Expanding indications of omalizumab therapy in the absence of specific IgE. Allergol Immunopathol 2011 May-Jun; 39(3): 189. 15. Khan S, Grimbacher B, Boecking C, Chee R, Allgar V, Holding S, Wong G, Huissoon A, Herriot R, Doré P, Sewell W. Serum Trough IgG level and Annual Intravenous Immunoglobulin Dose Are Not Related to Body Size in Patients on Regular Replacement Therapy. Drug Metab Lett. 2011 Apr 1; 5(2):132-6. 16. Khan S, Singh S. Practical issues for clinicians using high-dose intravenous immunoglobulin. Indian J Dermatology 2011Jan-March; 56(1): 122-3. 17. Khan S, Abuzakouk M, Doré PC, Sewell WA. Administering intravenous immunoglobulin during infection is associated with infusion reaction in selected patients. Irish Journal of Medical Sciences 2011 March; 180(1): 125-8. 18. Khan S. Regulatory T-cell detection by flow cytometry and systemic sclerosis. Clinical and Translational Science 2011 Feb; 4(1): 72. 19. Khan S, Philip S. Need to further investigate the efficacy of valproic acid in retinal degenerative disorders. British Journal of Ophthalmology [E-letter] http://bjo.bmj.com/content/95/1/89/reply#bjophthalmol_el_9897 7 February 2011. 20. Khan S, Deacock S. Omalizumab therapy to prevent anaphylaxis in systemic mastocytosis. Blood [E-letter] http://bloodjournal.hematologylibrary.org/cgi/eletters/116/26/5812 14 January 2011. 21. Khan S, Pereira J, Darbyshire PJ, Holding S, Doré PC, Sewell WA, Huissoon A. Do ribosomopathies explain some cases of common variable immunodeficiency? Clinical & Experimental Immunology 2011 January; 163(1): 96-103. 22. Sujoy Khan and Anand Zachariah. ‘Practice in the ICU: The case of organophosphate poisoning’. In: Towards a Critical Medical Practice. Reflections on the Dilemmas of Medical Culture Today. Edited by: Anand Zachariah, R Srivatsan and Susie Tharu on behalf of the CMC-Anveshi Collective. Orient Blackswan Publications. 2010. Hyderabad. India. Chapter 16, pages 285-298. 23. Khan S, Davies L, Cowley D, Wild G, Sewell WA. Anti-acetylcholine receptor antibody reactivity of IgG in commercial immunoglobulin preparations. Clin Neurol Neurosurg 2010 November; 112(9): 835-6. 24. Khan S. Nitric oxide generation after IVIG in sickle cell crises. Blood [E-letter] http://bloodjournal.hematologylibrary.org/cgi/eletters/116/5/687. 9 August 2010. 25. Sujoy Khan. Differences between IVIG products may lead to different outcomes in acute Kawasaki disease. Immunotherapeutics Quarterly 2010 August; 9(32): 6-7. 26. Khan S, Doré PC, Sewell WA. Intravenous immunoglobulin-induced neutropenia. Paediatr Allergy Immunol 2010 August 1; 21(5): 892-3. 27. Khan S, Holding S, Doré PC, Sewell WA. Pitfalls in the diagnosis of latex allergy. Allergology International 2010 July 29; 59(3): 305-8. 28. Khan S. Recurrent infections with Aspergillus require exclusion of defects in the phagocyte NADPH oxidase pathway. Indian J Medical Microbiology 2010 July-September; 28(3): 269. 29. Khan S. Anti-IL-5 therapy and DRESS. CMAJ 2010 Jun; 182(9): 941. 30. Khan S. Systemic capillary leak syndrome should be considered in the differential diagnosis of multi-organ failure and hypovolemic shock. Pediatr Infect Dis J. 2010 Jun;29(6):579-80. 31. Sujoy Khan. IVIG inhibits T cell response by impairing antigen presentation. Immunotherapeutics Quarterly 2010 March; 9(31): 4. 32. Sujoy Khan. IVIG regulates T cell function by inhibition of T cell proliferation. Immunotherapeutics Quarterly 2009 November; 8(30): 3. 33. Sujoy Khan. The ELISA Guidebook 2nd Edition. By: John R. Crowther. Humana Press; 2009. Published in: Immunology News for British Society for Immunology November 2009: 39-40. (Book Review) 34. Khan S, Myers K. Warfarin can be safe and effective in the extreme elderly. Age and Ageing 2009 November; 38(6): 763. 35. Khan S. The epithelial mucin MUC1 and virus-specific antibodies target cell-free human immunodeficiency virus in human breast milk. The Pediatric Infectious Disease Journal 2009 October; 28(10): 932. 36. Sujoy Khan. Basic and Clinical Immunology. By: Mark Peakman and Diego Vergani, Churchill Livingstone ELSEVIER; 2nd edition, 2009. Published in: The Bulletin of The Royal College of Pathologists October 2009; 148: 324. (Book Review) 37. Khan S, Abuzakouk MA. Immunology abstracts. Hospital Doctor of Ireland 2009: 15(4): 66- 68. 38. Khan S. Invasive cryptococcus infections in immunocompetent individuals may suggest defects in CD40/CD40L signaling pathway. Indian J Pathol Microbiol 2009 July-September; 52(3): 458-9. 39. Khan S, Campbell A, Hunt C, Sewell WA. Lichen planus in a case of Good’s syndrome (thymoma and immunodeficiency). Interact Cardiovasc Thorac Surg 2009 August; 9(2): 345- 346. 40. Khan S, Vaishnavi A. Pharmacotherapy for gastric antral vascular ectasia: dramatic response to tranexamic acid. Gastrointest Endosc 2009 July; 70(1): 191. 41. Sujoy Khan. Identification of the anti-inflammatory ‘IVIG receptor’. Immunotherapeutics Quarterly 2009 May; 8(29): 1-2. 42. Khan S. Immunological abnormalities in dyskeratosis congenita. Indian Paediatrics 2009 May; 46(5): 448. 43. Sujoy Khan, Manish Udiawar. Does C-peptide provide the link to prevention of complications in type 2 diabetes mellitus? CMAJ 2009 [E-letter; Available at: http://www.cmaj.ca/cgi/eletters/180/9/919]. 44. Khan S, Del-Duca C, Fenton E, Holding S, Hirst J, Doré PC, Sewell WA. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. Journal of Clinical Pathology 2009 May; 62(5): 439-441. 45. Sujoy Khan. How sensitive are the toxin detection kits for C. difficile infection? CMAJ 2009 [E-letter; Available at: http://www.cmaj.ca/cgi/eletters/180/6/627#83241]. 46. Khan S, Sims S, Raine D, Sewell WAC. Both autoantibodies and pathogen-specific antibodies are present in immunoglobulin preparations and reflect characteristics of the donor population. J Am Acad Dermatol 2008 December; 59(6): 1089-1090. 47. Khan S, Doré PC, Sewell WAC. The value of total IgE levels in the context of specific allergy. Paediatr Allergy Immunol 2008 December; 19(8): 777-778. 48. Sujoy Khan. Recombinant sialylated IgG Fc more effective than IVIG for autoimmune disease. Immunotherapeutics Quarterly 2008; 8(28): 4. 49. Khan S. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis. Med Hypotheses 2008 November; 71(5): 818. 50. S Khan, D Raine, A Vaishnavi. Autoantibodies in gastric antral vascular ectasia. CMAJ 2008 [E-letter; Available at: http://www.cmaj.ca/cgi/eletters/179/2/162]. 51. Khan S. Nimesulide and adverse drug reactions – Time for a database. J Postgrad Med 2008 July-September; 54(3): 242. 52. Khan S, Davies IB. Hypoxia and Alzheimer’s disease. CMAJ 2008 June 17; 178(13): 1687; author reply 1687-8. 53. Sujoy Khan. EndoS: enzyme with action on IgG shows promise for autoantibody-mediated disorders. Immunotherapeutics Quarterly 2008; 8(27): 4-5. 54. Sujoy Khan, WAC Sewell. Trapping the T cells – superagonist CD28 antibodies. Immunotherapeutics Quarterly 2008; 8(27): 6-7. 55. Khan S, Hinks J, Shorto J, Schwarz MJ, Sewell WA. Some cases of common variable immunodeficiency may be due to a mutation in the SBDS gene of Shwachman-Diamond syndrome. Clin Exp Immunol 2008 Mar; 151(3): 448-454. 56. Khan S, Alvi A, Holding S, Kemp M, Raine D, Doré PC, Sewell WA. The clinical significance of antinucleolar antibodies. Journal of Clinical Pathology 2008 Mar; 61(3): 283-286. [Article of the month on Phadia web site May 2008, available at: http://www.immunocap.com/dia_templates/Page____42463.aspx] 57. Khan S, Doré PC, Sewell WA. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease. Pediatr Allergy Immunol 2008 Mar; 19(2): 186-187. 58. Sujoy Khan. Pneumocystis jiroveci pneumonia can be a clue to underlying primary immunodeficiency disease. Arch Dis Child 2008 [E-letter; Available at: http://adc.bmj.com/cgi/eletters/93/6/545]. 59. Khan S, Holding S, Doré PC, Sewell WA. Abnormal glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome. Medical Hypotheses 2008; 70(2): 269-272. 60. Sujoy Khan. IVIG effects on Treg expansion and dendritic cell maturation in multiple sclerosis. Immunotherapeutics Quarterly Dec2007/Jan2008; 8(26): 2-3. 61. Khan S, Sewell WA. Risks of intravenous immunoglobulin in sepsis affect trial design. Ann Int Med 2007 Dec 4; 147(11): 813; author reply 813-4. 62. Khan S, Doré PC, Sewell WA. Anti-proteinase 3 antibodies utilise innate signalling pathways that lead to inflammation. J R Coll Physicians Edinb 2007 Dec; 37: 379. 63. Sujoy Khan. Immunoglobulin treatment of Kawasaki disease-factors that affect response. Immunotherapeutics Quarterly 2007 August; 8(25): 5-6. 64. Sujoy Khan. Sugars maintain the anti-inflammatory activity of IVIG. Immunotherapeutics Quarterly 2007 June; 7(24): 4-5. 65. Khan S, Doré PC, Sewell WA. Could oral spleen tyrosine kinase inhibitors lead to neoplastic transformation? Journal of Allergy and Clinical Immunology 2007 May; 119(5): 1277. 66. Khan S, Tarzi MD, Dore PC, Sewell WA, Longhurst HJ. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clinical Immunology 2007 April; 123 (1): 14-17. 67. Khan S, Sharrack B, Sewell WAC. Metronidazole-induced aseptic meningitis during Helicobacter pylori eradication therapy. Ann Intern Med 2007 Mar 6; 146(5): 395-396. 68. Sujoy Khan. Fingolimod- a new immunomodulator that alters lymphocyte homing patterns. Immunotherapeutics Quarterly 2007 January; 6(23): 5. 69. Sujoy Khan. Dendritic cells, TLR recognition and endotoxin tolerance in severe malarial infection. Malaria Journal 2007. [E-comment; Available at: http://www.malariajournal.com/content/5/1/101/comments#260550]. 70. Sujoy Khan. Platelet activating factor (PAF) and nitric oxide: a new look at anaphylaxis. Immunotherapeutics Quarterly 2006 October; 5(22): 20-21.

What I think of the idea behind WebmedCentral and WebmedCentral plus: